Johns Hopkins Institute for NanoBioTechnology: Delivering Treatment to Breast Cancer Cells Through Tiny Tubes
September 19, 2023
September 19, 2023
BALTIMORE, Maryland, Sept. 19 (TNSres) -- Johns Hopkins Institute for NanoBioTechnology issued the following news:
Breast cancer in its various forms affects more than 250,000 Americans a year. One particularly aggressive and hard-to-treat type is triple-negative breast cancer (TNBC), which lacks specific receptors targeted by existing treatments. The rapid growth and metastasis of this cancer also make it challenging to manage, leading to limited therapy options and an often poor p . . .
Breast cancer in its various forms affects more than 250,000 Americans a year. One particularly aggressive and hard-to-treat type is triple-negative breast cancer (TNBC), which lacks specific receptors targeted by existing treatments. The rapid growth and metastasis of this cancer also make it challenging to manage, leading to limited therapy options and an often poor p . . .